Clinical Trial Update: HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating an HDAC inhibitor in combination with chemoimmunotherapy as neoadjuvant treatment for pMMR locally advanced colon cancer,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Adenocarcinoma

Snippet

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Conditions: Colon Adenocarcinoma | Phase 2 | Status: RECRUITING